Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Outcomes An ED encounter with one of the following diagnoses within a year of the index event: DKA: ICD-10-CM code E10.1* or SNOMED code 420422005 Hypoglycemia: ICD-10-CM code E16.1, E16.2, or E10.64* Hyperglycemia: ICD-10-CM code E10.65* or SNOMED code 310505005 Stroke: ICD-10-CM code I60*, I63*, I69.3*, Z86.73, or G45.9 MI: ICD-10-CM code I21*-I23* Other T1D complications: ICD-10-CM E10.2*-E10.5*, or E10.61*-E10.63* A clinical encounter with the following diagnosis within a year of the index event: Lower body amputation: ICD-10-CM code Z89.41*-Z89.44*, Z89.51*, or Z89.61*
How do the costs compare
The global weight management market, which includes GLP-1 drugs, is projected to reach USD 70 billion by 2028
The primary outcomes were MACE (cardiovascular [CV] death, myocardial infarction, ischemic stroke, or hospitalization for heart failure) and composite kidney outcomes (estimated glomerular filtration rate [eGFR] decline of 50% or progression to dialysis)
US$ 22.05
US$ 27.35
US$ 24.71
US$ 24.27
